Previous Close | 8.4 |
1-Year Change | 1.94% |
6-Months Change | 34.19% |
3-Months Change | -8.1% |
Moving Avg (50d) | 9.0072 |
Moving Avg (200d) | 7.4461 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.977B |
Beta (3-Years) | 1.38 |
Revenue Growth (ttm) | 18.46% |
Net Profit Margin (ttm) | 1.4% |
Return On Assets (ttm) | 2.29% |
EPS (ttm) | -0.02 |
PE Ratio (ttm) | -420 |
Dividend Yield | % |
Asset Description: | MiMedx Group, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
8.568 | 8.82 | 8.988 | 9.24 | 9.66 | 10.08 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |